2.5 ml semaglutide 2mL Vial – Le Beau Visage Medical Spa Ozempic Semaglutide Injection Pen for

Why Choose Tri-County for Semaglutide

Key Safety Differentiators No IGF-1 elevation: AOD-9604 does not stimulate IGF-1, meaning it avoids risks such as organ/tissue overgrowth or acromegaly No glucose disruption: Clinical data shows it does not impair insulin sensitivity or worsen blood sugar regulation Comparable to placebo: In obesity trials, the incidence of adverse effects was similar to placebo groups, underscoring its tolerability Legal Status of AOD-9604 United States: AOD-9604 is not FDA-approved as a drug, dietary supplement, or weight loss therapy

It is appropriate for both men and women and can be integrated alongside other peptide or weight loss protocols

Parallel federal litigation is also underway, with similar claims from parents, school districts, and state Attorneys General